![Soo-Young Choi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Soo-Young Choi formerly worked at Eutilex Co., Ltd., as Co-Chief Executive Officer & Director from 2020 to 2023.
Dr. Choi received his undergraduate degree and graduate degree from Seoul National University and doctorate degree from Kyoto University.
Anciens postes connus de Soo-Young Choi
| Sociétés | Poste | Fin |
|---|---|---|
| EUTILEX.CO.,LTD | Directeur Général | 29/03/2023 |
Formation de Soo-Young Choi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyoto University
 Kyoto University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eutilex Co., Ltd.
 Eutilex Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops anti-tumor T cell therapy and antibody therapeutics based on proprietary immunotherapy technology | Health Technology |
